CSF1 and Parkinson disease: Although direct evidence supporting enhanced CSF1R expression in activated microglia due to a higher demand for CSF1 is lacking, an overall CSF1R upregulation has been observed in mouse models of amyloidosis and neurotoxic models of Parkinson's disease (Murphy Jr.